Grants per year
Personal profile
Research Interests
retinal detachment, diabetic retinopathy, macular degeneration, uveitis/retinitis, intravitreal injections, laser treatment, Retina diseases and surgery
Certifications and Licenses
| Ophthalmology |
Training Experience
| 1988 | Internship, New York Hospital/Cornell Medical Center |
| 1991 | Residency, Northwestern University, McGaw Medical Center |
| 1993 | Fellowship, Massachusetts Eye & Ear Infirmary |
Education/Academic qualification
MD, University of Chicago
… → 1987
Research interests
- Diabetes
Fingerprint Dive into the research topics where A Lyon is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 16 Similar Profiles
Cytomegalovirus Retinitis
Medicine & Life Sciences
Macular Degeneration
Medicine & Life Sciences
Retinal Detachment
Medicine & Life Sciences
Retinitis
Medicine & Life Sciences
Visual Acuity
Medicine & Life Sciences
Acquired Immunodeficiency Syndrome
Medicine & Life Sciences
Diabetes Complications
Medicine & Life Sciences
Uveitis
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 1998 2023
Prot #GEM-NH-002: A Prospective Natural History Study to Evaluate Clinical Characteristics and Disease Progression in Subjects with Non-Central Geographic Atrophy (GA) Who Are Carriers of High-Risk Genetic Variants of Complement Factor H (CFH)
PPD Investigator Services, LLC, Gemini Therapeutics, Inc.
11/4/19 → 11/4/22
Project: Research project
Prot #GEM-NH-001: A Genetic Screening and Registry Study to Evaluate Long-term Clinical Outcomes and Disease Progression in Subjects with Non-Central Geographic Atrophy (GA) Who Are Carriers of High-Risk Genetic Complement Variants Associated with Dry Age
PPD Investigator Services, LLC, Gemini Therapeutics, Inc.
11/4/19 → 11/4/22
Project: Research project
Prot #APL2-304: A Phase III, Multi-Center, Randomized, Double-Masked, Sham-Controlled Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy with Sham Injections in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Deg
Covance Inc., Apellis Pharmaceuticals, Inc.
1/25/19 → 1/25/22
Project: Research project
AMD Ryan Initiative Study (ARIS) LONGITUDINAL STUDY OF EARLY AMD AND RETICULAR PSEUDODRUSEN
EMMES Corporation, Kennedy Institute - National Eye Clinic
1/1/19 → 12/31/23
Project: Research project
Diabetic Retinopathy Clinical Research Network 2019-2023 Master Agreement
Jaeb Center for Health Research, Kennedy Institute - National Eye Clinic
1/1/19 → 12/31/23
Project: Research project
Diabetic Retinopathy
Chronic Disease
Eye Diseases
Diabetes Complications
Blindness
Research Output 1996 2019
3
Citations
(Scopus)
Diffuse Uveal Melanocytic Proliferation with Primary Vitreoretinal Lymphoma
Leskov, I., Lyon, A. T. & Jampol, L. M., Jul 1 2019, In : JAMA ophthalmology. 137, 7, p. 834-837 4 p.Research output: Contribution to journal › Article
Lymphoma
Neoplasms
Physical Examination
Biopsy
Diffuse Uveal Melanocytic Proliferation with Primary Vitreoretinal Lymphoma - Reply
Jampol, L. M., Leskov, I. & Lyon, A. T., Dec 2019, In : JAMA ophthalmology. 137, 12, p. 1466-1467 2 p.Research output: Contribution to journal › Letter
Lymphoma
2
Citations
(Scopus)
Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17
Age-Related Eye Disease Study 2 Research Group, Feb 2019, In : Ophthalmology. 126, 2, p. 261-273 13 p.Research output: Contribution to journal › Article
Eye Diseases
Macular Degeneration
Natural History
Confidence Intervals
Visual Acuity
1
Citation
(Scopus)
Oxidative stress and cardiovascular risk in type 1 diabetes mellitus: Insights from the DCCT/EDIC study
DCCT/EDIC Research Group, May 15 2018, In : Journal of the American Heart Association. 7, 10, e008368.Research output: Contribution to journal › Article
Diabetes Complications
Type 1 Diabetes Mellitus
Epidemiology
Oxidative Stress
Aryldialkylphosphatase
7
Citations
(Scopus)
Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema
Diabetic Retinopathy Clinical Research Network, Jul 1 2018, In : Ophthalmology. 125, 7, p. 1054-1063 10 p.Research output: Contribution to journal › Article
Endothelial Growth Factors
Macular Edema
Vascular Endothelial Growth Factor A
Therapeutics
Injections